Clinical trial

Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma

NCT06436040

Study summary

ClinicalTrials.gov

Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Pathological response assessment Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2024-01-24

PhaseN/A

Conditions

Tumor Microenvironmentunresolved

Lung Squamous Cell Carcinomaverified · MONDO: squamous cell lung carcinoma

Neoadjuvant Chemoimmunotherapyunresolved

Interventions

Pathological response assessmentOTHER

Sponsors & collaborators

Tang-Du Hospitallead sponsor

Mapped research locations

Xi’anShanxi, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06436040 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.